StockWatch: Pfizer Vaccine to Boost Revenues for Years
Demand for Pfizer's Covid-19 vaccine could boost its revenues for years.
Pfizer said it expected to sign more deals this year with several countries for 2022 and beyond.
Denmark became the first country to exclude Johnson &…
Read More
Read More